LABORATORY NEWS
-
Mangoceuticals Selects TRYBE Labs As Its Nationwide Blood Collection And Testing Services Provider
Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products via a secure telemedicine platform, including its uniquely formulated hair growth product branded ‘GROW’ and erectile dysfunction (ED) drug branded “Mango,” today announced that it has selected TRYBE Labs to provide its customers with a minimally invasive FDA approved at-home blood collection device and testing services as the Company seeks to further expand its product lines requiring blood tests and results reviewed by physicians.
- Atalan Adds Tricore To Its Technology-Enabled Clinical Partnership, Providing Greater Access To The Best In Laboratory Medicine
- Xact Laboratories Announces Strategic Partnership With A National Switch To Provide Integrated PGx Results At The Point Of Prescription Fulfillment
- ARUP Laboratories Urges FDA To Withdraw Proposed Rule Regulating Laboratory-Developed Tests
- Personalis And Tempus Enter Into A Strategic Collaboration To Advance Cancer Testing
ARCHIVED NEWSLETTER
- 11.28.23 -- Liquid Biopsy: The Next Evolution In Personalized Prostate Cancer Screening
- 11.14.23 -- Using Automation For Antimicrobial Screening
- 10.24.23 -- FDA's Proposed Laboratory-Developed Tests Rule Raises Many Questions But Provides Few Answers
- 10.10.23 -- BridgeBio's Approach To Gene Therapy & Nearing The Clinic With Dr. Eric David
- 09.26.23 -- Mechanistic Modeling To Optimize rAAV Production For Gene Therapy
This website uses cookies to ensure you get the best experience on our website. Learn more